TRMT1
protein-codingtRNA methyltransferase 1, the group of 7BS DNA/RNA methyltransferases
Gene summary
This gene encodes a tRNA-modifying enzyme that acts as a dimethyltransferase, modifying a single guanine residue at position 26 of the tRNA. The encoded enzyme has both mono- and dimethylase activity when exogenously expressed, and uses S-adenosyl methionine as a methyl donor. The C-terminal region of the encoded protein has both a zinc finger motif, and an arginine/proline-rich region. Mutations in this gene have been implicated in autosomal recessive intellectual disorder (ARID). Alternative splicing results in multiple transcript variants encoding different isoforms. There is a pseudogene of this gene on the X chromosome. [provided by RefSeq, May 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~12.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032665
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0032665
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0032665
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0000508
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0032665
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0100038
Submitter: ClinGen
The *TRMT1* gene encodes a tRNA methyltransferase involved in post-transcriptional RNA modification. *TRMT1* was first reported in relation to autosomal recessive complex neurodevelopmental disorder in 2011 (Najmabadi et al., PMID: 21937992). Clinical features include global developmental delay, intellectual disability, language deficits, and mild facial dysmorphism. Additional features in a subset of individuals can include behavioral abnormalities, seizures, microcephaly, short stature, gait abnormalities or poor coordination, and cerebral and/or cerebellar atrophy. Eleven variants (4 frameshift, 4 splice site, 2 nonsense and 1 missense) that have been reported in 10 probands in 5 publications (PMIDs: 21937992, 26308914, 30289604, 31898845, 40245862) are included in this curation. Variants in *TRMT1* segregated with disease in 7 additional family members. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is known to be loss of function. This gene-disease relationship is also supported by experimental evidence, including biochemical function, a zebrafish model and *in vitro* functional studies. Defects in multiple tRNA methyltransferases (*TRMT10A*, *WDR4*, *FTSJ1*, *ALKBH8*, *NSUN2*, and *NSUN6*) have been implicated in neurodevelopmental disorders with overlapping clinical features (PMID: 30415557). *TRMT1* knockout zebrafish have reduced brain and body size, increased locomotor behavior and decreased neuronal cell proliferation (PMID: 40245862). Patient-derived fibroblasts and lymphoblastoid cell lines harbouring bi-allelic *TRMT1* variants demonstrate significantly reduced levels of N2,N2-dimethylguanosine (m2,2G) in tRNA (PMID: 40245862). In summary, there is definitive evidence supporting the relationship between *TRMT1* and autosomal recessive complex neurodevelopmental disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on March 4, 2026 (SOP version 12).
Inheritance Pattern: AR
Disease ID:MONDO:0032665
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TRMT1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001136035.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 29 | 1 | 33 | ||
| missense | 2 | 155 | 10 | 167 | ||
| nonsense | 4 | 7 | 2 | 13 | ||
| start loss | 1 | 1 | ||||
| frameshift | 7 | 9 | 16 | |||
| splice donor/acceptor (+/-2bp) | 1 | 5 | 4 | 10 | ||
| Total | 12 | 23 | 165 | 39 | 1 | 240 |
Highest pathogenic variant AF is 0.00021877362
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001129507.1 | 16 | MANE Select | |
| Ensembl | ENSP00000350352.4 | 16 | MANE Select | |
| RefSeq | NP_001136026.1 | 15 | Standard | |
| RefSeq | NP_001338689.1 | 15 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- miR-targeted genes in epithelium - TarBase
- miR-targeted genes in lymphocytes - TarBase
- tRNA modification in the nucleus and cytosol
- tRNA processing
- Metabolism of RNA
Biological Process
- tRNA N2-guanine methylation
- tRNA modification
Molecular Function
- tRNA binding
- RNA binding
- tRNA (guanine-N2-)-methyltransferase activity
- protein binding
- metal ion binding
Cellular Component
- nucleus
- nucleoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000592062
- Coding exons
- 16
- Length
- 12666
- Individuals with no LoFs
- 125655
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 92
- Defined
- 125747
- p
- 0.000366
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.561 | 406 | 439 | 0.925 | 0.0000290 | 4224 |
| Missense (PolyPhen) | 71 | 94.709 | 0.74966 | 913 | ||
| Synonymous | -0.320 | 185 | 180 | 1.03 | 0.0000121 | 1372 |
| Loss of Function | 1.82 | 24 | 35.7 | 0.672 | 0.00000204 | 359 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00045 | 0.00043 | rare |
| Latino/Admixed American | 0.00018 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00071 | 0.00071 | rare |
| Finnish | 0.000096 | 0.000092 | rare |
| European (Non-Finnish) | 0.00035 | 0.00035 | rare |
| South Asian | 0.00062 | 0.00062 | rare |
| Other | 0.00085 | 0.00081 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Dimethylates a single guanine residue at position 26 of most tRNAs using S-adenosyl-L-methionine as donor of the methyl groups.;
Recessive Scores
- pRec
- 0.123
Intolerance Scores
- LoFtool
- 0.0725
- RVIS EVS
- -0.8
- RVIS percentile EVS
- 12.53
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.951
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |